Australia toll free: 1-800-037-942 | UK toll free: 0-808-189-1068
Singapore direct line: +65-6211-3710 ext 151
Supporting further improvements on neurological, cognitive and motor function recovery
Restorative and rehabilitation therapy is used to regain brain-body, cognitive (mental abilities) and motor function (such as ability to learn or to control of voluntary postures and movement patterns)1 . More interventions targeting multiple processes at the same time can help to promote recovery.
NeuroAiD™II supports patients undergoing rehabilitation*
NeuroAiD™II is a product containing 9 herbal extracts2 that undergoes extensive research and development, and of stringent quality control. Alongside rehabilitation, NeuroAiD™II amplifies self-repair of brain-body function processes2 , further improvement in quality of life.
Where can I find NeuroAiD?
Maximise your recovery with NeuroAiD™II
✔Capsules to be taken orally
✔2 capsules, 3 times a day
✔Course duration: Recommended 3 months*
✔Content can be diluted in water
NeuroAiDTM scientifically researched
Pharmacology and pre-clinical studies (made on cells cultures and animal models) have been conducted to determine the mechanisms of action of NeuroAiD, confirming the multimodal approach of the product.
Studies on NeuroAiD were led by medical experts, and study findings have been presented at international conferences and published in recognised journals.
More than 45 scientific papers have been published and the research remains active with ongoing trials and collaborations.
* The claims, indications, and recommendations may differ depending on the country registration status. Kindly contact us for further clarification.
1.Cramer SC, Sur M, Dobkin BH et al. Harnessing neuroplasticity for clinical applications. Brains 2011;134:1591-1609. doi: 10.1093/brain/awr039.
2.Heurteaux C, Gandin C, Borsotto M et al. Neuroprotective and neuroproliferative activities of NeuroAiD (MLC601, MLC901), a Chinese medicine, in vitro and in vivo. Neuropharmacology 2010; 58(7): 987 – 1001; doi: 10.1016/j.neuropharm.2010.01.001 you